Aptus Pharma Q2 Results
- BSE: 544529
- NSE: -
- ISIN: INE15XJ01010
- Sector: Biotechnology & Drugs
BSE
353.55
6.90 (1.99%)
6.90 (1.99%)Volume12.00 K
Updated: Wed 16 Sep, 2026 | 10:13:41
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Aptus Pharma Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | - | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 11.59 | - | N/A | - | N/A |
| Depreciation/ Amortization | 0.16 | - | N/A | - | N/A |
| Operating Income | 2.79 | - | N/A | 0.00 | 0.00% |
| Net Income | 1.75 | - | N/A | - | N/A |
| Other Operating Expenses Total | 3.30 | - | N/A | - | N/A |
| Net Income Before Taxes | 2.35 | - | N/A | - | N/A |
| Total Revenue | 14.38 | - | N/A | 0.00 | 0.00% |
| Selling/ General/ Admin Expenses Total | 2.30 | - | N/A | - | N/A |
| Diluted Normalized EPS | 1.02 | - | N/A | - | N/A |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.